R. Delva
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
-
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 26
- Renal cell carcinoma treatment 17
- Oncology 43
- Cancer Treatment and Pharmacology 25
- Colorectal Cancer Treatments and Studies 9
- PARP inhibition in cancer therapy 7
- Co-authors
- Érick Gamelin (9 shared papers)M. Boisdron‐Celle (8 shared papers)Alain Morel (2 shared papers)Christine Chevreau (23 shared papers)Véronique Guerin‐Meyer (2 shared papers)Norbert Ifrah (2 shared papers)Gwénaëlle Gravis (39 shared papers)Alain Lortholary (11 shared papers)
- Journals
- Journal of Clinical Oncology (39 papers)Annals of Oncology (14 papers)European Journal of Cancer (6 papers)Cancer Research (5 papers)Clinical Cancer Research (3 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
R. Delva
96 papers receiving 2.5k citations
R. Delva's Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 1.1k
- Cancer Research 393
- Reproductive Medicine 120
- Hematology 116
Countries citing papers authored by R. Delva
This map shows the geographic impact of R. Delva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Delva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Delva more than expected).
Fields of papers citing papers by R. Delva
This network shows the impact of papers produced by R. Delva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Delva. The network helps show where R. Delva may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Delva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial Hit paper breakdown → | 2015 | 325 |
| 2 | 2004 | 259 | |
| 3 | 2008 | 249 | |
| 4 | 1996 | 180 | |
| 5 | 2011 | 174 | |
| 6 | 1999 | 168 | |
| 7 | 2007 | 136 | |
| 8 | 2008 | 72 | |
| 9 | Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patients. | 1997 | 70 |
| 10 | 2008 | 59 | |
| 11 | 2013 | 57 | |
| 12 | 2006 | 52 | |
| 13 | 2012 | 48 | |
| 14 | 1999 | 42 | |
| 15 | 2014 | 42 | |
| 16 | 2005 | 40 | |
| 17 | 2010 | 38 | |
| 18 | 2011 | 34 | |
| 19 | 2006 | 31 | |
| 20 | 2015 | 27 |
About R. Delva
R. Delva is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Surgery and Molecular Biology, having authored 99 papers that have together received 2.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (26 papers), Cancer Treatment and Pharmacology (25 papers), Renal cell carcinoma treatment (17 papers), Testicular diseases and treatments (12 papers), Cancer, Lipids, and Metabolism (12 papers), Colorectal Cancer Treatments and Studies (9 papers), Breast Cancer Treatment Studies (8 papers) and PARP inhibition in cancer therapy (7 papers). The work is most often cited by research in Oncology (1.1k citations), Pulmonary and Respiratory Medicine (1.1k citations), Cancer Research (393 citations), Reproductive Medicine (120 citations) and Hematology (116 citations). R. Delva has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Érick Gamelin, M. Boisdron‐Celle, Alain Morel, Christine Chevreau, Véronique Guerin‐Meyer, Norbert Ifrah, Gwénaëlle Gravis, Alain Lortholary, Sylvie Négrier and F Larra. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.